Sheau Wen Lok 31st Lorne Cancer Conference 2019

Abstracts this author is presenting:

• A phase 1b dose-escalation and expansion study of the BCL-2 inhibitor venetoclax combined with tamoxifen in ER and BCL-2-positive metastatic breast cancer — Session 3: Breast and Prostate Cancer